Výsledky vyhledávání - "Eline L Huisman"

Akademický článek

Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands

Autor: Barnaby Hunt, Samuel J P Malkin, Robert G J Moes, Eline L Huisman, Tom Vandebrouck, Bruce H R Wolffenbuttel

Publikováno v: BMJ Open Diabetes Research & Care, Vol 7, Iss 1 (2019)

Objective Choosing therapies for type 2 diabetes that are both effective and cost-effective is vital as healthcare systems worldwide aim to maximize health of the population. The present analysis assessed the cost-effectiveness of once-weekly semaglu

Externí odkaz: https://doaj.org/article/9445410ffe204882b4b0fb77550491d8

Zobrazit plný text záznamu

Evaluating the Clinical and Economic Outcomes Associated with Poor Glycemic Control in People with Type 1 Diabetes in the Netherlands

Autor: Robert Gerald Jan Moes, Eline L Huisman, Samuel JP Malkin, Barnaby Hunt

Publikováno v: ClinicoEconomics and Outcomes Research.

Robert Gerald Jan Moes,1 Eline L Huisman,1 Samuel JP Malkin,2 Barnaby Hunt2 1Novo Nordisk BV, Alphen aan den Rijn, Netherlands; 2Ossian Health Economics and Communications, Basel, SwitzerlandCorrespondence: Barnaby Hunt, Ossian Health Economics and C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3633c4c013e424a9fdc82054889f4f3
https://www.dovepress.com/evaluating-the-clinical-and-economic-outcomes-associated-with-poor-gly-peer-reviewed-fulltext-article-CEOR

Zobrazit plný text záznamu

The long-term cost-effectiveness of oral semaglutide in the Netherlands based on the PIONEER 2, 3 and 4 randomized controlled trials

Autor: Barrie Chubb, Tobias S. Grand, Eline L. Huisman, Barnaby Hunt, Samuel J. P. Malkin

Publikováno v: Diabetes research and clinical practice. 175

Aims To assess the long-term cost-effectiveness of novel glucagon-like peptide-1 (GLP-1) analog oral semaglutide versus sodium-glucose cotransporter-2 inhibitor empagliflozin, dipeptidyl peptidase-4 inhibitor sitagliptin and injectable GLP-1 analog l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1272d4df640248a68078df15d35ba0e3
https://pubmed.ncbi.nlm.nih.gov/33744377

Zobrazit plný text záznamu

Clinical effectiveness of liraglutide vs basal insulin in a real-world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes

Autor: Arnout W. van Diermen, Edith M. Heintjes, Jetty A. Overbeek, Fernie J. A. Penning-van Beest, Ron M. C. Herings, Christian Klyver Tikkanen, Eline L. Huisman

Publikováno v: Overbeek, J A, Heintjes, E M, Huisman, E L, Tikkanen, C K, van Diermen, A W, Penning-van Beest, F J A & Herings, R M C 2018, ' Clinical effectiveness of liraglutide vs basal insulin in a real-world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes ', Diabetes, Obesity and Metabolism, vol. 20, no. 9, pp. 2093-2102 . https://doi.org/10.1111/dom.13335
Diabetes, Obesity & Metabolism
Diabetes, Obesity and Metabolism, 20(9), 2093-2102. Wiley-Blackwell

Aims: To compare real-world antidiabetic treatment outcomes over 12 months in obese people with type 2 diabetes mellitus (T2DM) who previously received oral antidiabetic therapy and then initiated a first injectable therapy with liraglutide or basal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::115e822195ec9263377288b423fcb87f
https://doi.org/10.1111/dom.13335

Zobrazit plný text záznamu

A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD

Autor: Eline L. Huisman, Afisi S. Ismaila, Yogesh Punekar, Katya Y. J. Sion, Ian Naya

Publikováno v: Pulmonary Therapy

Introduction Comparative data on the efficacies of long-acting muscarinic antagonist (LAMA) and long-acting β2-agonist (LABA) combinations for the treatment of moderate-to-very-severe chronic obstructive pulmonary disease (COPD) are limited. The aim

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36b452c88fc87327dc87574ff9647604
http://europepmc.org/articles/PMC6964204

Zobrazit plný text záznamu

Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands

Autor: Robert G J Moes, Samuel J. P. Malkin, Tom Vandebrouck, Eline L. Huisman, Bruce H. R. Wolffenbuttel, Barnaby Hunt

Publikováno v: BMJ Open Diabetes Research & Care, 7(1):000705. BMJ PUBLISHING GROUP

ObjectiveChoosing therapies for type 2 diabetes that are both effective and cost-effective is vital as healthcare systems worldwide aim to maximize health of the population. The present analysis assessed the cost-effectiveness of once-weekly semaglut

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c38357298b22003152d79671c39b11cc
https://research.rug.nl/en/publications/aeecdf30-6d65-41cf-8b5e-896b7d20af61

Zobrazit plný text záznamu

Economic evaluation of pooled solvent/detergent treated plasma versus single donor fresh-frozen plasma in patients receiving plasma transfusions in the United States

Autor: Maria A. de Peuter, Eline L. Huisman, Shamika U. de Silva

Publikováno v: Transfusion and Apheresis Science. 51:17-24

This study assessed the cost-effectiveness of Octaplas™ versus fresh frozen plasma (FFP) in patients receiving plasma transfusions in the United States (US). Acute and long-term complications of plasma transfusions were modelled in a decision tree

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de188bd22e8ef3a9e0165437b5695d52
https://doi.org/10.1016/j.transci.2014.07.006

Zobrazit plný text záznamu

Comparative efficacy of umeclidinium/vilanterol versus LABA/LAMA therapies in COPD: A network meta-analysis

Autor: Eline L. Huisman, Afisi S. Ismaila, Yogesh Suresh Punekar, Ian Naya, Katya Y. J. Sion, A. Karabis

Publikováno v: 5.1 Airway Pharmacology and Treatment.

Objective: To assess the comparative efficacy of umeclidinium/vilanterol 62.5/25µg OD (UMEC/VI) vs. available LABA/LAMA combinations in moderate-severe COPD. Methods: A systematic review identified randomized controlled trials (RCTs) ≥8 weeks in C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::08a862cccd8524e7948991fc7ca92b32
https://doi.org/10.1183/13993003.congress-2016.pa981

Zobrazit plný text záznamu

Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis

Autor: Eline L. Huisman, Yogesh Suresh Punekar, A. Karabis, Afisi S. Ismaila

Publikováno v: International Journal of Chronic Obstructive Pulmonary Disease

Afisi Segun Ismaila,1,2 Eline L Huisman,3 Yogesh Suresh Punekar,4 Andreas Karabis31Value Evidence and Outcomes, GlaxoSmithKline, Research Triangle Park, NC, USA; 2Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada; 3Re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a09ae75b9a9672d48ab2f58174784a2b
https://pubmed.ncbi.nlm.nih.gov/26604738

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání